Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple MyelomaChristina M. Annunziata, Louis M. Staudt, Yulia N. Demchenko et al.|Cancer Cell|2007Cited by 949
Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistanceLei Shi, Fenghuang Zhan|Oncotarget|2010Cited by 113
NEK2 mediates ALDH1A1-dependent drug resistance in multiple myelomaYe Yang, Fenghuang Zhan|Oncotarget|2014Cited by 72
TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignanciesCan Li, Fenghuang Zhan|Journal of Clinical Investigation|2021Cited by 42
Nek2 Is a Novel Regulator of B Cell Development and Immunological ResponseZhimin Gu, Fenghuang Zhan|BioMed Research International|2014Cited by 26